In a remarkable recognition of his work in muscular dystrophy research, Kevin P. Campbell, PhD, a distinguished professor at the University of Iowa, has been named the 2026 recipient of the prestigious August M. Watanabe Prize in Translational Research. This highly coveted award is one of the largest in the United States, celebrating those who successfully translate scientific findings into therapeutic advances.
The Indiana University School of Medicine awards the Watanabe Prize annually to senior investigators who have made impactful contributions to translational science. Campbell’s recognition highlights his significant influence in the field, particularly through his exploration of the molecular and cellular underpinnings of muscular dystrophy.
As the Roy J. and Lucille A. Carver Biomedical Research Chair in Molecular Physiology and Biophysics at the University of Iowa, Campbell also serves as the director of the Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center. Since joining the faculty in 1981, his pioneering research has laid the groundwork for innovative treatment approaches, offering new insights into skeletal muscle biology and muscular dystrophy disease mechanisms.
The Prize and Its Legacy
Campbell will be formally honored as the 2026 Watanabe Prize laureate with a $100,000 award. He is set to deliver the keynote address at the Indiana Clinical and Translational Sciences Institute’s annual meeting on September 18 in Indianapolis. The prize, named after the late August M. Watanabe, honors his legacy as a transformative figure in translational research, impacting global health through his leadership roles at both the IU School of Medicine and Eli Lilly and Company.
Note to Editors: This announcement was adapted from a news release issued by the Indiana University School of Medicine.
Read More Here
